- Management will discuss financial results for the third quarter ended September 30, 2017
- Management will also discuss the impact and outlook regarding the Philips contract cancellation announced on October 4, 2017
SUWANEE, Ga., Oct. 17, 2017 -- Digirad Corporation (NASDAQ:DRAD) will release financial results for its third quarter ended September 30, 2017, before the market opens on Friday, November 3, 2017. In addition, management will also discuss the recent announcement by Philips Healthcare to cancel its agreements with Digirad’s subsidiary, DMS Health Technologies, including financial impacts and forward strategy associated with its Medical Device Sales and Services business unit, as well as the Company’s overall strategy.
A conference call is scheduled for 11:00 a.m. EDT (8:00 a.m. PDT) on November 3, 2017 to discuss the results and management's outlook. The call may be accessed by dialing 1-877-407-9039 (international callers +1-201-689-8470). A simultaneous webcast of the call may be accessed online from the Events & Presentations link on the Investor Relations page of the Digirad website at http://drad.client.shareholder.com; an archived replay of the webcast will be available within 15 minutes of the end of the conference call.
About Digirad
Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis. Digirad's diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. For more information, please visit www.digirad.com.
For more information contact: Jeffry Keyes Chief Financial Officer 858-726-1600 [email protected]


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



